Pixantrone: a promising drug in the treatment of non-Hodgkin lymphomas. - Wikidata - awgldk - TriplyDB

Pixantrone: a promising drug in the treatment of non-Hodgkin lymphomas.

Pixantrone: a promising drug in the treatment of non-Hodgkin lymphomas.

http://www.wikidata.org/entity/Q37486763

about

Pharmacokinetic evaluation of pixantrone for the treatment of non-Hodgkin's lymphoma.

P2860

Q37929798-E4E49FB5-6C4D-4D7F-9E55-227E93FB90B3

P2860

Pixantrone: a promising drug in the treatment of non-Hodgkin lymphomas.

http://www.wikidata.org/entity/Q37486763

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pixantrone: a promising drug in the treatment of non-Hodgkin lymphomas.

@en

Pixantrone: a promising drug in the treatment of non-Hodgkin lymphomas.

@nl

type

label

Pixantrone: a promising drug in the treatment of non-Hodgkin lymphomas.

@en

Pixantrone: a promising drug in the treatment of non-Hodgkin lymphomas.

@nl

prefLabel

Pixantrone: a promising drug in the treatment of non-Hodgkin lymphomas.

@en

Pixantrone: a promising drug in the treatment of non-Hodgkin lymphomas.

@nl

P1433

Q37486763-85D34F99-8517-4439-ABB8-000B4656CFF8

P1476

Q37486763-F5AD8A4E-F3FD-4F8B-BADE-87390D12ACEF

P2093

Q37486763-A9A08516-040D-4D6F-B12B-8E8D0E6C50B5

Q37486763-EE84E8D2-DD4C-43AF-8D8E-309601DD98B3

P2860

Q37486763-10585908-6330-46A2-A315-A6FC8D62CA01

Q37486763-196079A0-BD3E-48F6-8720-8D2A64E58ABF

Q37486763-276BB8D9-42F7-485D-813A-69E72E6E586E

Q37486763-378E06E6-6666-4A32-9477-A0BE1032BF62

Q37486763-3BAE0E07-3643-4769-986E-56F49635BC04

Q37486763-41FC695C-9498-49A2-9336-DAF8BEC62FA8

Q37486763-4AFE3A9A-C796-49A7-BB56-2BB7F9DD85C9

Q37486763-5ED981E9-7BEA-41EE-9207-5B587EEA2EA3

Q37486763-72F25F0E-A70F-49C4-B61C-6A557F7DF069

Q37486763-8719CBA9-DD3B-4006-84FC-26B75E4DDB95

P304

Q37486763-0C335EF3-EA79-4B76-9156-303F82F20076

P31

Q37486763-9447743A-9D8D-46B6-AAFB-4B65DF1FF6AF

P356

Q37486763-4682DC7D-C865-4DFF-9A7C-DE1BBCA6A1C5

P407

Q37486763-3A4A94BF-A316-4D9B-9E04-02B935B0265E

P433

Q37486763-BA6C55D6-C4E4-42C7-B995-A697DC830968

P478

Q37486763-82ECCED5-B6B8-42C2-9D7F-72530705C75E

P577

Q37486763-61A5A6F1-FA5B-465C-84F4-95E0E726905F

P698

Q37486763-597A0994-8DF5-4F88-A28B-0C776DDE03AF

P356

P1433

Future Oncology

P1476

Pixantrone: a promising drug in the treatment of non-Hodgkin lymphomas.

@en

P2093

Barry W Hancock

http://www.w3.org/2001/XMLSchema#string

Loaie M El-Helw

http://www.w3.org/2001/XMLSchema#string

P2860

Gemcitabine as a single agent in the treatment of relapsed or refractory aggressive non-Hodgkin's lymphoma.

A clinical phase I and pharmacokinetic study of BBR 2778, a novel anthracenedione analogue, administered intravenously, 3 weekly.

Phase II trial of cis-dichlorodiammineplatinum (II) in advanced malignant lymphoma: a study of the cancer and acute leukemia group B.

DIZE (dexamethasone, idarubicin, and continuous infusion of ifosfamide and etoposide): an effective and well-tolerated new regimen for patients with relapsed lymphoma.

Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials.

Compared benefit of approved and experimental immunosuppressive therapeutic approaches in multiple sclerosis.

Molecular and cellular mechanisms of anthracycline cardiotoxicity.

The evolving role of etoposide in the management of lymphomas and Hodgkin's disease.

Liposomal daunorubicin in the treatment of relapsed or refractory non-Hodgkin's lymphoma.

Phase I study of BBR 2778, a new aza-anthracenedione, in advanced or refractory non-Hodgkin's lymphoma.

P304

445-453

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/FON.09.13

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19450173

http://www.w3.org/2001/XMLSchema#string